beta
Trial Radar AI

Showing clinical trials for Breast Neoplasm matching location: China.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

33 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Breast Neoplasm
×
 
Location
China
×
 
Biological Sex
All
×
 
Phase
Phase 2
×
 
Intervention
radiotherapy
×
 
Study Title
Status
Hypofractionated Online Adaptive Radiotherapy of Breast Cancer NCT06568705
Recruiting
A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. NCT06677879
Recruiting
A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer NCT06769919
Not yet recruiting
Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients NCT06404697
Recruiting
A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast NCT04481763
Recruiting
Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction NCT06464913
Recruiting
A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction NCT05692674
Recruiting
Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy NCT06498154
Recruiting
Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer NCT04947280
Recruiting
Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy NCT07113613
Recruiting
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (UNIQUE) NCT05762900
Recruiting
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer (CISN-L) NCT07254858
Not yet recruiting
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer NCT06914440
Recruiting
Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib NCT07396454
Recruiting
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors NCT03392233
Recruiting
SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) NCT06401005
Recruiting
Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients with Advanced HER2-Negative Breast Cancer with Brain Metastasis NCT06839560
Not yet recruiting
SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer NCT06402435
Recruiting
Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer (NEOTRIO-HR) NCT06671262
Recruiting
Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer NCT05804916
Recruiting
Response-Based Local Therapy for Regionally Advanced Breast Cancer NCT07376538
Recruiting
Phase II Clinical Trial of PD-L1 in Combination with Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy with or Without Radiotherapy for Advanced Triple-negative Breast Cancer. NCT06771609
Recruiting
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy NCT06596018
Recruiting
The Optimal Radioimmunotherapy Combinations for Advanced TNBC NCT06735131
Recruiting
Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. NCT06705127
Recruiting
Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC NCT06165900
Recruiting
Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer (NEOTRIO-2) NCT07457359
Recruiting
A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases NCT06088056
Not yet recruiting
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury NCT06847555
Recruiting
Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer NCT05861271
Recruiting
Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer. NCT07394387
Recruiting
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases NCT07100600
Recruiting
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients NCT05704166
Recruiting